References
- Aaby P, Samb B, Simondon F, Coll Seck AM, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunization: analysis of mortality studies from developing countries. BMJ 1995; 311: 481–5.
- Clemens JD, Stanton BF, Chakraborty J, Chowdhury S, Rao MR, Ali M, et al. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol 1988; 128: 1330–9.
- Aaby P, Samb B, Andersen M, Simondon F. No long-term excess mortality after measles infection: a community study from Senegal. Am J Epidemiol 1996; 143: 1035–41.
- Aaby P, Lisse I, Mølbak K, Knudsen K, Whittle H. No persistent T lymphocyte immunosuppression or increased mortality after measles infection: a community study from Guinea-Bissau. Pediatr Infect Dis J 1996; 15: 39–44.
- Lisse IM, Whittle H, Aaby P, Normark M, Gyhrs A, Ryder LP. Labelling of T-cell subsets under field conditions in tropical countries. Adaptation of the immuno-alkaline phospatase staining method for blood-smears. J Immunol Meth 1990; 129: 49–53.
- Garenne M. Variations in the age pattern of infant and child mortality with special reference to a case study in Ngayokheme (rural Senegal). PhD dissertation, University of Pennsylvania, 1982.
- Garenne M, Maire B, Fontaine O, Dieng K, Briend A. Risques de décès associés à différents états nutritionels chez l’enfant d’âge préscolaire. Dakar: ORSTOM, 1987.
- Chahnazarian A, Becker C, Delaunay V, Préziosi MP, Samb B, Simondon F, Simondon K. Population et santé à Niakhar, 1984–1991. Dakar: ORSTOM, 1992.
- Garenne M, Aaby P. Pattern of exposure and measles mortality in Senegal. J Infect Dis 1990; 161: 1088–94.
- Samb B, Aaby P, Whittle H, Coll Seck AM, Simondon F. Protective efficacy of high-titre measles vaccines administered from the age of five months in rural Senegal. Trans Roy Soc Trop Med Hyg 1993; 87: 697–701.
- Aaby P, Samb B, Simondon F, Knudsen K, Coll Seck AM, Bennett J, et al. Sex-specific survival after high titre measles vaccines in rural Senegal. Bull WHO 1994; 72: 761–70.
- Whittle HC, Mann G, Eccles M, O’Neill K, Jupp L, Hanlon P, et al. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4–5 months. Lancet 1988; i: 963–6.
- Erber WN, Pinching AJ, Mason DY. Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet 1984; i: 1042–6.
- Coovadia HM, Wesley A, Brain P. Immunological events in acute measles influencing outcome. Arch Dis Child 1978; 53: 861–7.
- Kiepiela P, Coovadia HM, Coward P. T helper cell defect related to severity of measles. Scand J Infect Dis 1987; 19: 185–92.
- Arneborn P, Biberfeld G. T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immunity 1983; 39: 29–37.
- Wesley A, Coovadia HM, Henderson L. Immunological recovery after measles. Clin Exp Immunol 1978; 32: 540–4.
- Dagan R, Phillip M, Sarov I, Epstein S, Kuperman O. Cellular immunity and T-lymphocyte subsets in young children with acute measles. J Med Virol 1987; 22: 175–82.
- Joffe MI, Sukha NR, Rabson AR. Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid. J Clin Invest 1983; 72: 971–80.
- Ohga S, Miyazaki C, Okada K, Akazawa K, Ueda K. The inflammatory cytokines in measles: correlation between serum interferon-gamma levels and lymphocyte subpopulations. Eur J Pediatr 1992; 151: 492–6.
- Alpert G, Leibovitz L, Danon YL. Analysis of T-lymphocyte subsets in measles. J Inf Dis 1984; 149: 1018.
- Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis 1993; 168: 275–81.
- Lisse IM, Bo¨ttiger B, Christensen LB, Knudsen K, Aaby P, Gottschau A, et al. Evaluation of T-cell subsets by an immunocytochemical method compared to flow cytometry in four countries. Scand J Immunol 1997; 45: 637–44.
- Lisse I, Aaby P, Whittle H, Jensen H, Engelman M. T-lymphocyte subsets in West African children: impact of age, season and sex. J Pediatr 1997; 130: 77–85.
- Aaby P, Bukh J, Kronborg D, Lisse IM, da Silva MC. Delayed excess mortality after exposure to measles during the first six months of life. Am J Epidemiol 1990; 132: 211–9.
- Halsey N. Increased mortality following high titer measles vaccines: too much of a good thing. Pediatr Infect Dis J 1993; 12: 462–5.
- Karp CL, Wysocka, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, et al. Mechanism of suppression of cell-mediated immunity by measles infection. Science 1996 273 228–31.